Toxicity management and efficacy of carboplatin desensitization therapy for recurrent epithelial ovarian carcinoma: A real-world study

Epithelial Ovarian cancer (EOC) is the most lethal gynecologic cancer worldwide. Carboplatin (CP) is the main chemotherapeutic agent in the treatment of ovarian cancer. However, the development of a hypersensitivity reaction (HSR) in 10% to 15% of patients with EOC is an important limiting factor fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Paksoy, Nail, Khanmammadov, Nijat, Doğan, İzzet, Ferhatoğlu, Ferhat, Yildiz, Anil, Ak, Naziye, Aydiner, Adnan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662820/
https://www.ncbi.nlm.nih.gov/pubmed/36397338
http://dx.doi.org/10.1097/MD.0000000000031726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662820/
https://www.ncbi.nlm.nih.gov/pubmed/36397338
http://dx.doi.org/10.1097/MD.0000000000031726

Ejemplares similares